Israel Englander’s ChemoCentryx, Inc. CCXI Stock Holding History

Israel Englander’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-360,000	Closed	-$6.16M	–	7667
2021 Q3	$6.16M	Buy	360,000 +260,000	+260%	+$4.05M	﹤0.01%	2622
2021 Q2	$1.34M	Buy	+100,000	New	+$2.46M	﹤0.01%	4389
2019 Q4	–	Sell	-303,400	Closed	-$2.06M	–	4772
2019 Q3	$2.06M	Hold	303,400	–	–	﹤0.01%	2425
2019 Q2	$2.82M	Buy	+303,400	New	+$3.51M	﹤0.01%	2198
2013 Q4	–	Sell	-151,900	Closed	-$845K	–	3886
2013 Q3	$845K	Buy	+151,900	New	+$1.64M	﹤0.01%	2227

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Israel Englander's CCXI Position: Q4 2022 in Review

Israel Englander sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 983,809 shares — an estimated $50.8M sold.

Israel Englander first reported a position in CCXI in Q2 2013 and held it in 33 quarters. The position peaked at $50.8M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Israel Englander reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Israel Englander sold 983,809 ChemoCentryx, Inc. shares in Q4 2022, an estimated $50.8M.
Israel Englander first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 33 quarters.
Israel Englander's ChemoCentryx, Inc. position peaked at $50.8M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.